共 16 条
[1]
BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS
[J].
BMJ-BRITISH MEDICAL JOURNAL,
1987, 295 (6605)
:1017-1020
[3]
CREUTZIG A, 1988, VASA-J VASCULAR DIS, V17, P77
[4]
CREUTZIG A, 1987, INT J MICROCIRC, V5, P373
[5]
DULING BR, 1975, FED PROC, V34, P2012
[9]
Messmer K, 1972, ADV MICROCIRC, V4, P1